Patient Engagement Software That Unlocks the Full Potential of Your GLP-1 Therapies

PatientPartner uniquely empowers patients on GLP-1 treatments. Whether for weight management, metabolic health, or diabetes care, by easing uncertainty, sustaining long-term adherence, and delivering authentic peer connections at scale.

See the platform in action

30,000

Patient Members

500+

Patient Mentors

150+

Disease states covered

<1Day

Avg. connection made

LP-1 Therapies, Real Patient Transformations

GLP-1 treatments face unique hurdles—from medical complexities to lifestyle adjustments and stigmas—making relatable peer support indispensable. Here’s how real patients have leveraged personalized mentorship to accelerate their journeys:

+35% Faster Dose Titration

Reached targeted dosing schedule 35% quicker with mentor guidance.

Jordan S.

Type 2 Diabetes

+28% Greater Weight Loss

Lost nearly 30% more weight in the first month than expected.

Maria T.

Obesity Management

+45% Faster Lifestyle Changes

Adopted healthy habits 45% faster with peer support.

Alex K.

Prediabetes

+22% Better Control

Managed PCOS symptoms better with mentorship.

Priya R.

PCOS

+30% Higher Adherence Rate

30% better injection consistency with mentor support.

Daniel L.

Metabolic Syndrome

Learn More

Common Challenges in GLP-1 Therapy Adoption

Patient Stigma, Uncertainty & Isolation

With countless brands and conflicting online advice, prospective GLP-1 users often feel overwhelmed—and have nowhere to turn for relatable, trusted guidance.

Hesitation Around Side Effects & Lifestyle Changes

From nausea and GI upset to diet and activity adjustments, the real-world demands of GLP-1 treatments can deter patients without ongoing peer support.

Poor Long-Term Adherence

Early enthusiasm can fade as side effects persist and motivation wanes - leading to higher discontinuation rates and suboptimal health outcomes.

Sabina K.

Type 1 Diabetes

Patient Sentiment

Feeling isolated

Peer Support

No Options Available

Time to Diagnosis

2.5 years

Time to Treatment

5.0 years

PatientPartner’s Proven Solutions for GLP-1 Therapy

Instant Peer-to-Peer Mentorship

Prospective GLP-1 patients are matched in real time with mentors who’ve successfully navigated their own weight-loss and metabolic journeys—offering practical tips on dosing, managing side effects, and sustaining lifestyle changes.

Measurable Treatment Initiation & Adherence

GLP-1 prospects connected with a mentor are up to 68% more likely to start therapy, and those who engage stay on treatment 30% longer, driving better health outcomes and maximizing lifetime value.

Actionable Real-World Patient Insights

Capture deep, first-hand feedback on patient sentiment, barrier moments, and “Aha!” strategies from each mentor conversation—empowering your teams to refine support programs, optimize communications, and accelerate GLP-1 adoption.

Ava M.

Muscular Dystrophy

Patient Sentiment

Feeling hopeful

Peer Support

Matched Mentor

Time to Diagnosis

1.2 years

Time to Treatment

2.2 years

How It Works

1. Patient Matching

Patients are instantly connected through our patented, real-time mentorship matching platform, pairing each patient with a mentor experienced with their exact disease state.

2. Personalized Support

Utilizing advanced sentiment analytics, PatientPartner ensures every patient-mentor interaction is tailored for maximum impact, addressing unique emotional and informational needs.

3. Actionable Outcomes

Experience measurable patient activation — 85% of patients progress confidently to their next treatment milestone, significantly above industry standards.

Results & Impact

71% More Patient Activation

Patients engaging with peer mentors through PatientPartner are significantly more likely to initiate and continue their treatment plans.

Stronger Patient Trust

Over 90% of mentored patients report increased confidence and reduced anxiety about their rare disease treatments.

Clinical and Financial ROI

Improved adherence and patient activation drive both clinical outcomes and meaningful ROI for pharma and med-tech providers.

Learn More

Compliant by Design

PatientPartner meets and exceeds regulatory standards, including HIPAA, SOC 2, and ISO 27001, providing integrated, real-time compliance tracking to safeguard patient information and mitigate risk.

AICPA SOC Compliant

GDPR Compliant

ISO 27001 Compliant

HIPAA Compliant

Ready to Transform Your Rare Disease Patient Engagement?

Book your personalized demo and see exactly how PatientPartner drives measurable results for rare disease treatments.

Learn More

Drive Results with 2025 Direct to Patient Marketing Trends Analysis Report

Download the 2025 Direct to Patient Marketing Trends Analysis Report to find out exactly how pharma & med-tech leaders are modernizing their approach to achieve higher patient adoption and sustained treatment adherence.

Thank you for your interest in our white paper! We hope you find it valuable.

Oops! Something went wrong while submitting the form.

Book a Demo

Patient Engagement Software That Unlocks the Full Potential of Your GLP-1 Therapies

LP-1 Therapies, Real Patient Transformations

Common Challenges in GLP-1 Therapy Adoption

PatientPartner’s Proven Solutions for GLP-1 Therapy

How It Works

Results & Impact

Compliant by Design

Ready to Transform Your Rare Disease Patient Engagement?

Drive Results with 2025 Direct to Patient Marketing Trends Analysis Report